by jlohrconsulting | Sep 1, 2025 | Uncategorized
Pediatr Blood Cancer. 2025 Aug 31:e31998. doi: 10.1002/pbc.31998. Online ahead of print. ABSTRACT BACKGROUND: Adolescents and young adults (AYAs) receiving hematopoietic cell transplantation (HCT) for malignancy are at risk for poor psychological outcomes. Promoting...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Psychogeriatrics. 2025 Sep;25(5):e70091. doi: 10.1111/psyg.70091. ABSTRACT BACKGROUND: Social restrictions during the novel coronavirus 2019 disease (COVID-19) pandemic negatively impacted the mental health of older adults. This study aimed to examine the associations...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Women Health. 2025 Sep 1:1-20. doi: 10.1080/03630242.2025.2547608. Online ahead of print. ABSTRACT Female Genital Mutilation (FGM) is a deeply ingrained cultural practice in many regions of sub-Saharan Africa, involving the partial or complete removal of external...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
J Food Sci. 2025 Sep;90(9):e70500. doi: 10.1111/1750-3841.70500. ABSTRACT Zanthoxylum bungeanum Maxim., a traditional Chinese cash crop, produces pericarps (huajiao) that are widely used as condiments and herbal medicines. Zanthoxylum bungeanum Maxim. essential oil...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Pain Manag. 2025 Sep 1:1-10. doi: 10.1080/17581869.2025.2550923. Online ahead of print. ABSTRACT Fremanezumab is a monoclonal antibody inhibiting the CGRP signaling leading to migraine prophylaxis. Its efficacy and potential safety concerns are updated here. All...
Recent Comments